Launch Planning in Digital-First Reality: How can a Traditional “Reach and Frequency” Model be Adapted to Omnichannel Future
In this episode of Pharma Launch Secrets, Bozidar is joined by Peter Marchesini, Senior Vice President at Indegene.
Altri episodi di "Pharma Launch Secrets"
Launching with Influencers: How to Leverage KOLs, DOLs and New Channels to Engage Healthcare Professionals Authentically During Your Product Launch
44:33In this episode, Bozidar is joined by Brian Kaiser, Executive Vice President and Head of Strategy at Klick Health, as well as Thomas Engstrom, Global Group Director of Influencer Marketing at Klick Health.
Non perdere nemmeno un episodio di “Pharma Launch Secrets”. Iscriviti all'app gratuita GetPodcast.
23 Years Later: Co-founder of Indegene Shares How Life Sciences Companies Reimagine Commercialization in 2023 in the Digital-First Reality
37:31In this episode, Bozidar is joined by Gaurav Kapoor, Executive Vice President of Indegene to share how Life Sciences companies reimagine commercialization in 2023 in the Digital-First Reality.
How Outdated FDA Regulations Affect the New World of Pharma Launches? With Dale Cooke, President of Philly Cooke Consulting
37:57In this episode of Pharma Launch Secrets, Bozidar is joined by Dale Cooke, President of PhillyCooke Consulting, a company that focuses on ensuring that relevant stakeholders understand FDA regulatory requirements for the different categories of products and how to apply those regulations to new and emerging technology channels.
Bridging the “Pharma-Startup Gap”: How Can Pharma Companies and Digital-Health Startups Work Effectively to Bring Products to Market Faster
32:06In this episode of Pharma Launch Secrets, Bozidar is joined by Naomi Fried, CEO, and Founder of PharmStars. If you’re a pharma or startup executive and wondering about how to bridge the pharma-startup gap, this episode could be just what you need to hear. Tune in to this episode of Pharma Launch Secrets, a Podcast by Evermed.